• Need a new search?

    If you didn't find what you were looking for, try a new search!

    Generic filters
    Exact matches only
    Search in title
    Search in content
    Search in excerpt
    18 10, 2017

    Maternal Bipolar Disorder Not a Predictor of Infant Developmental Deficits at One Year of Age

    By |2017-10-18T10:04:42-04:00October 18th, 2017|Bipolar Disorder, Psychiatric Disorders During Pregnancy|

      While some women with bipolar disorder elect to discontinue their psychotropic medications during pregnancy to mitigate fetal exposure, Viguera and colleagues (2000, 2007) found that women stabilized on lithium face a significant risk for [...]

    12 02, 2016

    Are Women with Bipolar Disorder at Risk of Illness After Miscarriage?

    By |2016-02-22T23:13:18-04:00February 12th, 2016|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|

    Women with bipolar disorder are at significant risk for recurrent illness during the postpartum period.  After miscarriage, an event which is associated with both hormonal changes and psychological complexity, is the risk for recurrent illness [...]

    10 09, 2015

    Conference News from ECNP: High Risk of Psychopathology in the Offspring of Parents with Bipolar Disorder and Schizophrenia

    By |2015-09-10T11:14:02-04:00September 10th, 2015|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|

    Children whose parents have either schizophrenia or bipolar disorder are at high risk for psychopathology.  There are genetic factors which influence vulnerability to illness, but environmental influences also play a role.  Data presented at the [...]

    19 09, 2009

    New Research:  Treatment Decisions by Pregnant Women with Bipolar Disorder 

    By |2016-03-28T13:23:58-04:00September 19th, 2009|New Research, Psychiatric Disorders During Pregnancy|

    Choosing whether to maintain or discontinue mood stabilizer treatment during pregnancy requires weighing the risks of teratogenic outcomes associated with exposure to a particular drug against the risks of recurrence of untreated affective illness.   However, [...]

    Go to Top